Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis
Author:
Funder
National Research Foundation
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy
Link
http://link.springer.com/content/pdf/10.1186/s12992-019-0485-7.pdf
Reference43 articles.
1. Son K-B, Lee T-J. Compulsory licensing of pharmaceuticals reconsidered: current situation and implications for access to medicines. Global Public Health. 2017:1–11.
2. Beall R, Kuhn R. Trends in compulsory licensing of pharmaceuticals since the Doha declaration: a database analysis. PLoS Med. 2012;9(1):e1001154.
3. FM’t Hoen E, Veraldi J, Toebes B, Hogerzeil HV. Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016. Bulletin of the World Health Organization. 2018;96(3):185.
4. Son K-B, Lee T-J. The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: implications for domestic legislations in low-and middle-income countries. Global Public Health. 2018;13(9):1169–78.
5. Kuek V, Phillips K, Kohler JC. Access to medicines and domestic compulsory licensing: learning from Canada and Thailand. Global public health. 2011;6(2):111–24.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Resolving the patents paradox in the era of COVID-19 and climate change: Towards a patents taxonomy;Research Policy;2023-11
2. Global and regional governance of One Health and implications for global health security;The Lancet;2023-02
3. Balancing WTO-TRIPS Standard Against Nigeria Counterfeit Regulatory Efforts;International Journal of Public and Private Perspectives on Healthcare, Culture, and the Environment;2022-06-10
4. The COVID‐19 pandemic and long‐term incentives for developing vaccines: Patent law under stress;The Journal of World Intellectual Property;2022-03-31
5. Compulsory Licensing of Pharmaceuticals in High‐Income Countries: A Comparative Analysis;The Milbank Quarterly;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3